Observational Study of Atrial Fibrillation Ablation Outcomes
This study, called VIBRANT-AF, is looking for adults aged 18 and older who have undergone a catheter ablation procedure for atrial fibrillation (a type of irregular heartbeat). The goal is to understand what factors lead to successful outcomes and what causes complications after this procedure. You would use a smartphone app and email to answer surveys over one year about your lifestyle, if your atrial fibrillation returns, hospitalizations, and your general feelings. The study aims to identify real-world experiences of patients across the US, not just those in specialized centers. There are no specific interventions being tested in this study; it's about observing and collecting information.
- Study design
- This is an observational study planning to enroll 1125 participants. It is designed to follow participants over time to collect information.
- What's involved
- You would connect with the Eureka Research Platform and answer a series of surveys and activities over a one-year period. You will be asked weekly survey questions on habits, complications, medication usage, and hospitalizations.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for a period of one year to measure the time until atrial fibrillation returns.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation
At a glance
Conditions
NCT05504356
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of California, San Francisco
San Francisco, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Gregory Marcus, MD, MAS · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Time to Atrial Fibrillation Recurrence1 year
Time to atrial fibrillation, after employing a 3-month blanking period. Atrial Fibrillation Recurrence includes patient-reported symptoms of AF or Kardia-based ECG evidence of AF.